Joint SIRIRAJ-NCGM Symposium 5th NCGM/CCS/DIT Symposium on Clinical Research and Trials

INTRODUCTION

Infectious diseases continue to cause alarming morbidity and mortality rates in Asia. Lessons learned from past outbreaks have highlighted the importance of fast and efficient vaccine trials in protecting millions of people. Testing of vaccines in regions where they are most prevalent is an ideal setting to assess effectiveness. As the world eagerly awaits the development of safe and effective vaccines, it is crucial to explore strategies that can enhance the overall efficiency of vaccine trial process.

By bringing together diverse perspectives and expertise, this symposium aims to: 

• Promote knowledge sharing and exchange of best practices
• Discuss areas of collaboration improvement, and
• Explore potential solutions that will help streamline the operations and processes involved in implementing vaccine trials specific to the country

EVENT INFORMATION

• DATE AND TIME：November 22, 2024, 13:30 to 16:30 UTC/GMT +7
• FORMAT：Onsite and Online via ZOOM
• LANGUAGE：English
• REGISTRATION：Registration is free. Please register from here
• CONTACT：arise@hosp.ncgm.go.jp
• Download flyer

PROGRAM

• MC:
• Dr. Suvimol Niyomnaitham
• Vice Director, Clinical Research Support, Siriraj Institute of Clinical Research (SICRES), Siriraj Hospital Faculty of Medicine, Mahidol University, Thailand
• Ms. Marlinang Siburian
• Specially appointed Researcher, Department of International Trials, Center for Clinical Sciences (CCS), NCGM, Japan

• 13:30-13:33 Opening remarks
• Dr. Hideyo Miyazaki
• Hospital Director, National Center for Global Health and Medicine (NCGM), Japan

• 13:33 – 13:37 Objectives & Agenda of the Symposium

• 13:37 – 14:10 Keynote Speech
• "Overcoming Challenges in Vaccine Trials: Ethical, Logistical, and Engagement Strategies for Optimal Success" 
• Assoc. Prof. Dr. Winai Ratanasuwan
• Director, SICRES, Siriraj Hospital Faculty of Medicine, Mahidol University, Thailand

• 14:10 – 14:30 Presentation 1 + Q&A
• Effective Communication and Stakeholder Collaboration
• Prof. Dr. Jarir At Thobari
• Director, Clinical Epidemiology and Biostatistics Unit (CEBU), Faculty of Medicine, Public Health and Nursing (FMPHN), Universitas Gadjah Mada (UGM), Indonesia

• 14:30 – 14:50 Presentation 2 + Q&A
• "Patient Engagement in Vaccine Trials"
• Prof. Dr. Kulkanya Chokephaibulkit
• Professor of Pediatric Infectious Diseases, Siriraj Hospital Faculty of Medicine, Mahidol University, Thailand

• 14:50 – 15:00 Break

• 15:00 – 15:20 Presentation 3 + Q&A
• Protocol compliance
• Prof. Dr. Punnee Pitisuttithum
• Professor Emeritus, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

• 15:20 – 15:40 Presentation 4 + Q&A
• "Lesson Learned from COVID-19 Vaccine Development and Approaches for Future Vaccine Development"
• Dr. Fumihiko Takeshita
• Vice President, R&D Division, Research Function, Vaccine Research Laboratories, Daiichi-Sankyo, Japan

• 15:40 – 16:25 Panel Discussion
• "How to Collaborate to Accelerate Vaccine Development in Asia"
• Chair:
• Dr. Wataru Sugiura
• Director, Center for Clinical Sciences, NCGM, Japan
• Panelists:
  • Assoc. Prof. Dr. Winai Ratanasuwan
  • Prof. Dr. Jarir At Thobari
  • Prof. Dr. Kulkanya Chokephaibulkit
  • Prof. Dr. Punnee Pitisuttithum
  • Dr. Fumihiko Takeshita
  • Dr. Eriko Morino
  • Section Chief of Clinical Research Management Office, Department of Clinical Research Promotion, CCS, NCGM, Japan
  • Dr. Marie Grace Dawn Isidro
  • Principal Investigator, West Visayas State University, Philippines

• 16:25 – 16:30 Closing and announcements
• Dr. Muchanga Sifa
• Senior Researcher, Department of International Trials, CCS, NCGM, Japan